Talk:N-Methyl-Cyclazodone: Difference between revisions

>Carphknight
Unfinished draft
>Blackhole
m 0xea moved page N-Methyl-Cyclazodone to Talk:N-Methyl-Cyclazodone over redirect: moving to "talk" namespace for visibility
 
(24 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{headerpanel|{{approval}}{{stub}}}}
{{SummarySheet}}
{{SummarySheet}}
{{SubstanceBox/NMC}}
{{SubstanceBox/N-Methyl-Cyclazodone}}
{{decree|type=notice|message=This article is in the 'Talk' namespace because it is an unfinished draft. This section is used to host drafts for unpublished articles as well as discussions for published ones. If you'd like to use this area to discuss this draft, please do so in the 'Discussion' section at the very bottom of the page. This notice will be removed once this draft has been approved for publication by an administrator.}}
{{headerpanel|{{approval}}{{stub}}}}




'''N-Cyclopropyl-N-Methylpemoline''' (also known as '''N-Methyl-Cyclazodone''' or '''NMC''') is a novel [[psychoactive class::stimulant]] substance of the [[chemical class::4-oxazolidinone]] class. It is structurally related to [[thozalinone]] and [[cyclazodone]]. Similar to [[amphetamine]], the addition of the methyl group on [[cyclazodone]] is thought to increase its potency and duration. The mechanism of action involves promoting the release of [[dopamine]], [[norepinephrine]], and [[serotonin]] in the brain.
'''N-Cyclopropyl-N-Methylpemoline''' (also known as '''N-Methyl-Cyclazodone''' or '''NMC''') is a novel [[psychoactive class::stimulant]] substance of the [[chemical class::4-oxazolidinone]] class. is structurally related to [[thozalinone]] and [[cyclazodone]]. Similar to [[amphetamine]], the addition of the methyl group on [[cyclazodone]] is thought to increase its potency and duration. The mechanism of action involves promoting the release of [[dopamine]], [[norepinephrine]], and [[serotonin]] in the brain.


Unlike [[cyclazodone]], '''N-methyl-cyclazodone''' has little to no history of use and only recently emerged as a study aid. Its non-clinical use has only found recent attention as a [[research chemical]] study aid or atypical [[antidepressant]]. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants or [[antidepressants]]. Similar to [[methamphetamine]], this substance is reported to possess an usually long duration, it is therefore recommended to take one's dose in the morning and avoid redosing.
Unlike [[cyclazodone]], N-methyl-cyclazodone has little to no history of use and only recently emerged as a study aid. Its non-clinical use has only found recent attention as a [[research chemical]] study aid or atypical [[antidepressant]]. It should be noted that the lack of pharmacological data and extremely limited history of human usage pose considerable concern regarding its long-term use as a substitute for prescription stimulants or [[antidepressants]]. Similar to [[methamphetamine]], this substance is reported to possess an usually long duration, it is therefore recommended to take one's dose in the morning and avoid redosing.


[[Subjective effects]] include [[stimulation]], [[focus enhancement]], [[stamina enhancement]], [[increased blood pressure]], and mild [[euphoria]]. Some anecdotal reports suggest that '''N-methyl-cyclazodone''' and its parent compound [[cyclazodone]] may have nootropic properties similar to central nervous system stimulants such as [[methylphenidate]] and [[amphetamine]].
[[Subjective effects]] include [[stimulation]], [[focus enhancement]], [[stamina enhancement]], [[increased blood pressure]], and mild [[euphoria]]. Some anecdotal reports suggest that '''N-methyl-cyclazodone''' and its parent compound [[cyclazodone]] may have nootropic properties similar to central nervous system stimulants such as [[methylphenidate]] and [[amphetamine]].
Line 13: Line 12:
One of its parent compounds, [[thozalinone]], has been used as an [[antidepressant]] in europe<ref>{{cite journal | vauthors = Gallant DM, Bishop MP, Scrignar CB, Hornsby L, Moore B, Inturrisi BB | title = A double-blind study of thozalinone (C1 39,808) in depressed outpatients | journal = Current Therapeutic Research, Clinical and Experimental | volume = 8 | issue = 12 | pages = 621–2 | date = December 1966 | pmid = 4962734 }}</ref>, which may be due to its serotonin-releasing properties.
One of its parent compounds, [[thozalinone]], has been used as an [[antidepressant]] in europe<ref>{{cite journal | vauthors = Gallant DM, Bishop MP, Scrignar CB, Hornsby L, Moore B, Inturrisi BB | title = A double-blind study of thozalinone (C1 39,808) in depressed outpatients | journal = Current Therapeutic Research, Clinical and Experimental | volume = 8 | issue = 12 | pages = 621–2 | date = December 1966 | pmid = 4962734 }}</ref>, which may be due to its serotonin-releasing properties.


'''N-methyl-cyclazodone''' has no documented history of recreational human usage before it appeared on the online research chemical market in 2017. Based on related compounds, it is speculated that it likely possesses hepatotoxic and other not-yet-known toxic properties.  
N-methyl-cyclazodone has no documented history of recreational human usage before it appeared on the online research chemical market in 2017. Based on related compounds, it is speculated that it likely possesses hepatotoxic and other not-yet-known toxic properties.  


It is strongly advised to use [[responsible drug use|harm reduction practices]] if using this substance.
It is strongly advised to use [[responsible drug use|harm reduction practices]] if using this substance.
Line 23: Line 22:


==Pharmacology==
==Pharmacology==
N-Methyl-Cyclazodone is an approximately 4x - 6x more potent N,N-methylcyclopropyl derivative of [[pemoline]]. Pemoline is considered to be [[dopamine|dopaminergic]], but its precise method of action has not been fully determined.<ref>"Cylert (Pemoline)" (PDF). FDA. December 2002.</ref> Pemoline has minimal affinity for [[noradrenaline]] receptors and thus has minimal sympathomimetic side effects compared with typical dopaminergic central nervous system stimulants such as methylphenidate and [[Isomer|dextro]]-amphetamine.
N-Methyl-Cyclazodone is an approximately 4x - 6x more potent N,N-methylcyclopropyl derivative of [[pemoline]]. Pemoline is considered to be [[dopamine|dopaminergic]], but its precise method of action has not been fully determined.<ref>"Cylert (Pemoline)" (PDF). FDA. December 2002.</ref> Pemoline has minimal affinity for [[noradrenaline]] receptors and thus has “minimal” sympathomimetic side effects, (although increased dopamine release is thought to cause an increse in more the release  of norepinephrine thereby cussing sympathomimetic effects)


==Subjective effects==
==Subjective effects==
Line 32: Line 31:


|{{effects/physical|
|{{effects/physical|
*'''[[Effect::Stimulation]]''' - N-methyl-cyclazodone is reported to be somewhat stimulating though soft in a fashion that is generally weaker to that of [[methamphetamine]], but stronger than that of [[modafinil]], [[caffeine]], and [[methylphenidate]].
*'''[[Effect::Stimulation]]''' - N-methyl-cyclazodone is reported to be somewhat stimulating though soft in a fashion that is generally weaker than [[methamphetamine]], but stronger than [[modafinil]], [[caffeine]], and [[methylphenidate]]. It can encourage physical activities such as dancing, socializing, running, or cleaning. The particular style of stimulation which amphetamine produces can be described as forced.
*'''[[Effect::Physical euphoria]]''' - This effect is dose dependent and tends only to be present at higher doses. N-methyl-cyclazodone is reported to lack the body glow associated with [[amphetamine]] at typical doses.  
*'''[[Effect::Physical euphoria]]''' - This effect is dose dependent and tends only to be present at higher doses. N-methyl-cyclazodone is reported to lack the body glow associated with [[amphetamine]] at typical doses.  
*'''[[Effect::Stamina enhancement]]'''
*'''[[Effect::Stamina enhancement]]'''
Line 70: Line 69:
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Analysis enhancement]]'''
*'''[[Effect::Anxiety]]''' & '''[[Effect::Paranoia]]''' - This effect is dose dependent and typically occurs with overly high doses or after redosing and staying awake for extended periods of time.
*'''[[Effect::Anxiety]]''' & '''[[Effect::Paranoia]]''' - This effect is dose dependent and typically occurs with overly high doses or after redosing and staying awake for extended periods of time.
*'''[[Effect::Anxiety suppression]]''' - The anxiolytic effects of N-methyl-cyclazodone are generally weaker than those of [[cyclazodone]]
*'''[[Effect::Anxiety suppression]]''' - The anxiolytic effects of N-methyl-cyclazodone are generally weaker than those of [[cyclazodone]].
*'''[[Effect::Cognitive euphoria]]''' - This effect is dose dependent; a low dose will tend to produce only that of a slight mood lift and moderate to high doses are typically reported to be on par with that of [[amphetamine]] though less than that of [[methamphetamine]], [[3-FMA]], and [[4-methylaminorex]]. It is the strongest when used infrequently at moderate doses, and binges often result in a loss of this effect.
*'''[[Effect::Cognitive euphoria]]''' - This effect is dose dependent; a low dose will tend to produce only that of a slight mood lift and moderate to high doses are typically reported to be on par with that of [[amphetamine]], though less than that of [[methamphetamine]] and [[3-FMA]]. It is the strongest when used infrequently at moderate doses, and binges often result in a loss of this effect.
*'''[[Effect::Empathy, affection, and sociability enhancement]]''' - N-methyl-cyclazodone has been reported to produce low to moderately strong prosocial and entactogenic effects which, although much weaker than that of traditional entactogens such as [[MDMA]], surpass that of [[amphetamine]]. As with most amphetamine-like stimulants, this effect rapidly fades with prolonged use.
*'''[[Effect::Empathy, affection, and sociability enhancement]]''' - N-methyl-cyclazodone has been reported to produce low to moderately strong prosocial and entactogenic effects which, although much weaker than that of traditional entactogens such as [[MDMA]], surpass that of [[amphetamine]]. As with most amphetamine-like stimulants, this effect rapidly fades with prolonged use.
*'''[[Effect::Compulsive redosing]]''' - This effect is generally much less prominent than with [[cyclazodone]] mostly due its long duration
*'''[[Effect::Compulsive redosing]]''' - This effect is generally much less prominent than with [[cyclazodone]] mostly due its long duration.
*'''[[Effect::Delusion]]'''
*'''[[Effect::Delusion]]'''
*'''[[Effect::Disinhibition]]'''
*'''[[Effect::Disinhibition]]'''
*'''[[Effect::Ego inflation]]'''
*'''[[Effect::Ego inflation]]'''
*'''[[Effect::Emotion suppression]]'''
*'''[[Effect::Emotion suppression]]'''
*'''[[Effect::Focus enhancement]]'''
*'''[[Effect::Focus enhancement]]''' - N-methyl-cyclazodone is reported to produce strong focus-enhancing effects that rival common ADHD stimulants such as [[amphetamine]] and [[methylphenidate]].
*'''[[Effect::Increased libido]]'''
*'''[[Effect::Increased libido]]'''
*'''[[Effect::Increased music appreciation]]''' - This effect is usually weaker than with [[cyclazodone]]
*'''[[Effect::Increased music appreciation]]''' - This effect is usually weaker than with [[cyclazodone]].
*'''[[Effect::Motivation enhancement]]'''
*'''[[Effect::Motivation enhancement]]'''
*'''[[Effect::Bodily control enhancement]]'''
*'''[[Effect::Bodily control enhancement]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Thought acceleration]]'''
*'''[[Effect::Thought organization]]
*'''[[Effect::Thought organization]]
*'''[[Effect::Wakefulness]]''' - This effect is reported to be similar to [[methamphetamine]], with some users reporting an inability to sleep. It is advised to take one's dose at the start of the day to minimize this effect.
*'''[[Effect::Wakefulness]]''' - This effect is reported to be similar in duration to [[methamphetamine]], with some users reporting an inability to sleep. It is advised to take one's dose at the start of the day to minimize this effect.
*'''[[Effect::Time distortion]]''' - This can be described as the experience of time speeding up and passing much quicker than it usually would when sober.
*'''[[Effect::Time distortion]]''' - This can be described as the experience of time speeding up and passing much quicker than it usually would when sober.


}}
}}
{{effects/aftereffects|
{{effects/aftereffects|
The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. The "comedown" of N-methyl-cyclazodone is supposedly weaker and smoother and that of [[cyclazodone]], with some users reporting to after effects at all. Its effects commonly include:
The effects which occur during the [[offset]] of a [[stimulant]] experience generally feel negative and uncomfortable in comparison to the effects which occurred during its [[peak]]. This is often referred to as a "comedown" and occurs because of [[neurotransmitter]] depletion. The "comedown" of N-methyl-cyclazodone is generally weaker and smoother and that of [[cyclazodone]], with some users reporting no after effects at all. Its effects commonly include:
*'''[[Effect::Anxiety]]'''
*'''[[Effect::Anxiety]]'''
*'''[[Effect::Cognitive fatigue]]'''
*'''[[Effect::Cognitive fatigue]]'''
Return to "N-Methyl-Cyclazodone" page.